New Products
  1. Cat.No. Product Name Information
  2. GC28246 2-(Methylthio)-7,8-dihydroquinazolin-5(6H)-one

    2-(Methylthio)-7,8-dihydroquinazolin-5(6H)-one is a compound featuring a saturated ring fused to an aromatic (hetero)cyclic ring.

    2-(Methylthio)-7,8-dihydroquinazolin-5(6H)-one
  3. GK10050 JC-1 Mitochondrial Membrane Potential Assay Kit JC-1 Mitochondrial Membrane Potential Assay Kit is a reagent kit that uses JC-1 as a fluorescent probe to rapidly and sensitively detect changes in the mitochondrial membrane potential of cells. JC-1 Mitochondrial Membrane Potential Assay Kit
  4. GC28245 JNJ-26489112

    JNJ-26489112 is a CNS-active agent and inhibitor of voltage-gated Na+ channels and N-type Ca2+ channels with broad-spectrum anticonvulsant activity in rodents and can be used to study neurological disorders.

    JNJ-26489112
  5. GC28244 HALOFUGINONE LACTATE

    HALOFUGINONE LACTATE is a halogenated derivative of febrifugine, a natural quinazolinone-containing compound found in the Chinese herb D. febrifuga.

    HALOFUGINONE LACTATE
  6. GC28243 Sulcardine 2HCl

    Sulcardine 2HCl is a multi-ion channel blocker with antiarrhythmic effects that blocks the properties of hERG and hNav1.5 channels and can be used to study atrial fibrillation and ventricular arrhythmias.

    Sulcardine 2HCl
  7. GC28242 Anisodine

    Anisodine is an inhibitor of muscarinic acetylcholine receptors (mAChR) with neuroprotective activity, used in research on multiple myeloma and metastatic breast cancer.

    Anisodine
  8. GC28241 Selinexor HCl

    Selinexor HCl (1393477-72-9 free base) is an oral selective XPO1 (XPO1/CRM1) inhibitor that induces cell cycle arrest and apoptosis in tumor cells by blocking the transport of tumor suppressor proteins from the nucleus to the cytoplasm, thereby promoting their accumulation within the nucleus.

    Selinexor HCl
  9. GC28239 VRT-325

    VRT-325 is a CFTR modulator with the ability to promote ΔF508-CFTR folding and endoplasmic reticulum trafficking.

    VRT-325
  10. GC28240 Ivacaftor-D9

    Ivacaftor-D9 is transmembrane conductance regulator (CFTR) channel activator, is used potentially for the treatment of cystic fibrosis.

    Ivacaftor-D9
  11. GC28238 P7-2302

    P7-2302 inhibits PDE7 and PDE4B with IC50 values of 0.18 nM and 77.3 nM, respectively. It also inhibits the efflux of P-gp and BCRP (breast cancer resistance protein) and shows low uptake in rat brains.

    P7-2302

More

  1. Cat.No. Product Name Information
  2. GC14665 YM 58483 store-operated Ca2+ entry (SOCE) blocker YM 58483
  3. GC38641 IRL-1620 TFA IRL-1620 TFA is a potent and selective endothelin B receptor (ETB) agonist (Ki=16pM). IRL-1620 TFA
  4. GC30937 IRL-1620 IRL-1620 is a potent and selective endothelin B receptor (ETB) agonist (Ki=16pM). IRL-1620
  5. GC12907 Cy5 NHS ester Cy5 NHS ester is an amine-reactive near-infrared fluorescent labeling reagent (Ex/Em=650/670nm). Cy5 NHS ester
  6. GF02960 TCEP Solution (0.5M in Water) TCEP Solution (0.5M in Water) is a trialkylphosphine reagent that selectively reduces protein disulfides and promotes NF-κB-DNA binding. TCEP Solution (0.5M in Water)
  7. GD01599 Azocasein Azocasein is a useful tracer molecule for characterizing the permeability of the top coat of the multilayer-coated polyester threads. Azocasein
  8. GN20149 m7G(5')ppp(5')(2'OMeA)pG

    m7G(5')ppp(5')(2'OMeA)pG is an mRNA 5′cap analog belonging to the Cap 1 class with a 2′-O-methyl modification.

    m7G(5')ppp(5')(2'OMeA)pG
  9. GM10017 Cy5 Fluc mRNA with N1-Me-pUTP (5’CAP)

    Cy5 Fluc mRNA with N1-Me-pUTP (5'CAP) is a luciferase mRNA transcribed in vitro by simulating mRNA processing in eukaryotes. Cy5 Fluc mRNA with N1-Me-pUTP (5'CAP) carries Cy5-UTP modification, N1-Me-pUTP modification (Cy5-UTP: N1-Me-pUTP=3:1 (molar ratio)), Cap 1 cap structure, and poly (A) tail, which enhances mRNA stability and translation efficiency.

    Cy5 Fluc mRNA with N1-Me-pUTP (5’CAP)
  10. GC16841 Adefovir Dipivoxil Reverse transcriptase inhibitor Adefovir Dipivoxil
  11. GM10016 Cy5 eGFP mRNA with N1-Me-pUTP (5’CAP)

    Cy5 eGFP mRNA with N1-Me-pUTP (5'CAP) is a green fluorescent protein mRNA transcribed in vitro by simulating mRNA processing in eukaryotes. Cy5 eGFP mRNA with N1-Me-pUTP (5’CAP) carries Cy5-UTP modification, N1-Me-pUTP modification (Cy5-UTP: N1-Me-pUTP=3:1 (molar ratio)), Cap 1 cap structure, and poly (A) tail, increasing mRNA stability and translation efficiency.

    Cy5 eGFP mRNA with N1-Me-pUTP (5’CAP)

More